Perceptive Advisors’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-300,000
Closed -$9.45M 133
2018
Q1
$9.45M Sell
300,000
-50,000
-14% -$1.58M 0.26% 60
2017
Q4
$10.2M Buy
+350,000
New +$9.53M 0.34% 53
2016
Q4
Sell
-179,506
Closed -$4.32M 191
2016
Q3
$4.32M Sell
179,506
-4,001
-2% -$105K 0.28% 72
2016
Q2
$4.88M Buy
183,507
+180,511
+6,025% +$5.29M 0.34% 58
2016
Q1
$82K Hold
2,996
0.01% 160
2015
Q4
$93K Sell
2,996
-215,683
-99% -$6.54M 0.01% 148
2015
Q3
$5.76M Buy
218,679
+37,179
+20% +$1.24M 0.46% 49
2015
Q2
$6.55M Buy
181,500
+180,000
+12,000% +$6.32M 0.39% 56
2015
Q1
$52K Buy
+1,500
New +$54.4K ﹤0.01% 152

Other funds holding CLLS

Perceptive Advisors's CLLS Position: Q2 2018 in Review

Perceptive Advisors sold out of Cellectis (CLLS) in Q2 2018, closing a stake of 300,000 shares — an estimated $9.45M sold.

Perceptive Advisors first reported a position in CLLS in Q1 2015 and held it in 9 quarters. The position peaked at $10.2M in Q4 2017. 86 funds tracked by Wall St. Rank hold CLLS as of Q2 2018.

  • Perceptive Advisors reported no remaining Cellectis position as of Q2 2018 after selling out during the quarter.
  • Perceptive Advisors sold 300,000 Cellectis shares in Q2 2018, an estimated $9.45M.
  • Perceptive Advisors first reported a position in Cellectis in Q1 2015 and held it in 9 quarters.
  • Perceptive Advisors's Cellectis position peaked at $10.2M in Q4 2017.
  • 86 funds tracked by Wall St. Rank held Cellectis as of Q2 2018.

Based on Perceptive Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.